Serina Therapeutics Inc Stock Ownership - Who owns Serina Therapeutics?

Insider buying vs selling

Have Serina Therapeutics Inc insiders been buying or selling?
Steven MintzDirector2024-06-252,600$9.00
Steven MintzDirector2024-06-215,000$9.50
Gregory BaileyDirector2024-05-305,205$9.50
Gregory BaileyDirector2024-05-291,173$9.50
Gregory BaileyDirector2024-05-289,019$9.50
Gregory BaileyDirector2024-05-232,371$9.50
Steven MintzDirector2024-05-216,651$10.00
Steven MintzDirector2024-05-212,500$9.75
Gregory BaileyDirector2024-05-211,422$9.50
Gregory BaileyDirector2024-05-21916$9.50

1 of 2

SER insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SER insiders and whales buy or sell their stock.

SER Shareholders

What type of owners hold Serina Therapeutics Inc stock?
Juvenescence Ltd195.48%16,447,500$177.63MInsider
Juvenescence Us Corp195.48%16,447,500$177.63MInsider
Steven A. Ledger2.71%227,927$2.46MInsider
John F. Mauldin1.49%125,000$1.35MInsider
Broadwood Capital Inc1.01%85,219$920.37kInstitution
Tacey Viegas0.70%58,610$632.99kInsider
Judith Segall0.63%52,624$568.34kInsider
Michael D. West0.50%41,982$453.41kInsider
Donnis L. Casey0.28%23,725$256.23kInsider
Steven Mintz0.28%23,287$251.50kInsider

1 of 3

SER vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SER0.33%99.67%Net BuyingNet Buying
CVM13.82%40.65%Net BuyingNet Buying
MAIA3.03%20.26%Net BuyingNet Buying
MRNS81.79%18.21%Net Buying
GRTS43.16%20.31%Net SellingNet Selling

Serina Therapeutics Stock Ownership FAQ

Who owns Serina Therapeutics?

Serina Therapeutics (NYSEMKT: SER) is owned by 1.31% institutional shareholders, 397.92% Serina Therapeutics insiders, and 0.00% retail investors. Juvenescence Ltd is the largest individual Serina Therapeutics shareholder, owning 16.45M shares representing 195.48% of the company. Juvenescence Ltd's Serina Therapeutics shares are currently valued at $145.40M.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.